Literature DB >> 952828

Corneal changes in patients treated with clofazimine.

P E Wålinder, L Gip, M Stempa.   

Abstract

Fine, brownish lines, similar to chloroquine keratopathy, were observed in two of 19 psoriatic patients given clofazimine. There was no functional disturbance and the changes were reversible.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 952828      PMCID： PMC1017544          DOI： 10.1136/bjo.60.7.526

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  6 in total

1.  THE IRON LINES OF THE SUPERFICIAL CORNEA.

Authors:  J D GASS
Journal:  Arch Ophthalmol       Date:  1964-03

2.  'B 663' POSSIBLE ANTI-INFLAMMATORY ACTION IN LEPROMATOUS LEPROSY.

Authors:  S G BROWNE
Journal:  Lepr Rev       Date:  1965-01       Impact factor: 0.537

3.  A new series of phenazines (rimino-compounds) with high antituberculosis activity.

Authors:  V C BARRY; J G BELTON; M L CONALTY; J M DENNENY; D W EDWARD; J F O'SULLIVAN; D TWOMEY; F WINDER
Journal:  Nature       Date:  1957-05-18       Impact factor: 49.962

4.  A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663).

Authors:  F M Imkamp
Journal:  Lepr Rev       Date:  1968-07       Impact factor: 0.537

5.  Vortex patterns of the corneal epithelium.

Authors:  A J Bron
Journal:  Trans Ophthalmol Soc U K       Date:  1973

6.  Letter: Ocular side-effects of clofazimine.

Authors:  L Ohman; I Wahlberg
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321
  6 in total
  2 in total

Review 1.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

Review 2.  Drug-induced corneal deposits: an up-to-date review.

Authors:  Jean-Yves Sahyoun; Saama Sabeti; Marie-Claude Robert
Journal:  BMJ Open Ophthalmol       Date:  2022-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.